Guardant Health
GH
#1347
Rank
HK$132.66 B
Marketcap
HK$1,000
Share price
-3.16%
Change (1 day)
162.53%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

ESG Reports

Thumbnail Guardant Health
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report
Thumbnail Guardant Health
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report